1. J. Briede, M. Stiviriņa, D. Stoldere. E. Bisenieks, J. Ulkdriķis, J. Poikāns, N, Makarova, and G. Duburs, Effect of new and known 1,4-dihydropyridine derivatives on blood glucose levels in normal and streptozoticin-induced diabetic rate, Cell. Biochem. Funct., 22, 219–224 (2004).
2. M. A. S. Fernandes, M. S. Santos, J. M. Moreno, G. Duburs, C. R. Oliviera, and A. F. Vicente. Glibenclamide interferes with mitochondrial bioenergetics by inducing changes in ion permeability, J. Biochem. Mol. Toxicol., 18, 162–169 (2004).
3. B. Jansone, R. Muceniece, V. Kluša, Š. Svirskis, R. Petrovska, G. Duburs, and J. E. S. Wikberg, The non-peptide compound cerebrocrast is a highly effective melanocortin MC4 receptor agonist and inhibits feeding, Proc. Latv. Acad. Sci., Sect. B, 58, 103–108 (2004).
4. A. Sobolev, M. C. R. Franssen, G. Duburs, and Ae. De Groot, Chemoenzymatic synthesis of enantiopure 1,4-dihydropurine derivatives, Biocatal. Biotransform., 22, 231–252 (2004).
5. E. V. Ivanov, T. V. Ponomareva, G. N. Merkushev, I. K. Romanovich, G. Ya. Dubur, E. A. Bisenieks, Ya. R. Uddrikis, and Ya. Ya. Poikans, Radiomodification properties of derivatives of 1,4-dihydropyridine and 1,2,3,4,5,6,7,8,9,10-decahydroacridin-1,8-dione, Radiatsionnaya Biologiya. Radioekologiya, 44, 550–559 (2004).